Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
AbbVie Inc.

AbbVie Inc. (ABBV) Stock Overview

Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.

ABBV●NYSE
HealthcareDrug Manufacturers - General
$285.64
$0.45(0.16%)
U.S. Market opens in 18h 52m

AbbVie Inc. (ABBV)

Meyka AI Score

Z

Key Financials

Market Cap504.7B
P/E Ratio80.46
EPS (TTM)$10.19
ROE-1.36%
Fundamental Analysis

AI Price Forecasts

1 Month$277.79
3 Months$259.81
1 Year Target$242.02

ABBV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of AbbVie Inc. (NYSE: ABBV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, AbbVie Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABBV on the NYSE shows an RSI of 65.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $242.02 for the NYSE listing.

Key metrics behind AbbVie Inc.'s NYSE-traded stock include a P/E ratio of 80.46 and a market capitalization of 504.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABBV on the NYSE.

Price Performance (NYSE: ABBV)

1-Day Change
0.14%
5-Day Change
0.69%
1-Month Change
7.73%
3-Month Change
11.16%
6-Month Change
42.11%
Year-to-Date (YTD) Change
24.99%
1-Year Change
25.12%
3-Year Change
97.32%
5-Year Change
163.21%
All-Time (Max) Change
715.94%

Contact Information

https://www.abbvie.com
847 932 7900
1 North Waukegan Road, North Chicago, IL, 60064-6400

Company Facts

570,000 Employees
IPO DateJan 2, 2013
CountryUS
Actively Trading

Frequently Asked Questions